Page last updated: 2024-10-26

dipyridamole and Emphysema

dipyridamole has been researched along with Emphysema in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Emphysema: A pathological accumulation of air in tissues or organs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shih, WJ1
Li, CY1
Kiefer, V1
REESCHUCH, K1
ULMER, WT1

Other Studies

2 other studies available for dipyridamole and Emphysema

ArticleYear
Significance of the visualization of bone marrow during dipyridamole Tc-99m tetrofosmin myocardial and gated SPECT.
    Clinical nuclear medicine, 2002, Volume: 27, Issue:11

    Topics: Aged; Anemia; Bone Marrow; Chest Pain; Dipyridamole; Emphysema; Female; Gated Blood-Pool Imaging; He

2002
[Fuctional analytical studies on the effect of 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine on the lung].
    Arzneimittel-Forschung, 1963, Volume: 13

    Topics: Blood Gas Analysis; Dipyridamole; Emphysema; Humans; Lung; Pyrimidines; Silicosis; Spirometry

1963